semaglutide and nausea How to Avoid Sickness While Taking Ozempic: Semaglutide is a GLP-1
Description
Semaglutide can cause nausea, vomiting, or reduced appetite, particularly during the early stages of treatment
In this six-month prospective cohort study, 200 adults ages 18 to 65 with a BMI of 25 kg/m or higher (classified as overweight or obese) were enrolled and prescribed either the GLP-1 receptor agonist semaglutide or the dual GLP-1/GIP agonist tirzepatide
Trustpilot Reviews: What Customers Say Peptide Partners Trustpilot reviews now total 82+ from verified customers
Cagrilintide targets the amylin receptor pathway, which complements GLP-1 mechanisms through different appetite regulation circuits
This difference in receptor targeting may influence their efficacy and side effect profiles
